ES2090790T3 - Derivados de glicolipidos. - Google Patents

Derivados de glicolipidos.

Info

Publication number
ES2090790T3
ES2090790T3 ES93111255T ES93111255T ES2090790T3 ES 2090790 T3 ES2090790 T3 ES 2090790T3 ES 93111255 T ES93111255 T ES 93111255T ES 93111255 T ES93111255 T ES 93111255T ES 2090790 T3 ES2090790 T3 ES 2090790T3
Authority
ES
Spain
Prior art keywords
chem
glycolipid derivatives
agents
glycolipid
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93111255T
Other languages
English (en)
Inventor
Yutaka Yamada
Naofumi Takahashi
Keisuke Adachi
Akihiko Kameyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oil Mills Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Application granted granted Critical
Publication of ES2090790T3 publication Critical patent/ES2090790T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN DERIVADOS GLICOLIPIDOS DE LA FORMULA (1), EN LA QUE X ES UN GRUPO SELECCIONADO DE Y N ES 0 O UN ENTERO ENTRE 1 Y 10 Y R INDICA UNA CADENA DE HIDROCARBONO RAMIFICADA, CONTENIENDO DE 19 A 39 ATOMOS DE CARBONO. ESTOS COMPUESTOS SON UTILES COMO AGENTES ANTIINFLAMATORIOS, AGENTES PARA EL TRATAMIENTO DE ARTRITIS REUMATICA Y LA INHIBICION DE METASTASIS DEL CANCER.
ES93111255T 1992-07-15 1993-07-15 Derivados de glicolipidos. Expired - Lifetime ES2090790T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18800192 1992-07-15

Publications (1)

Publication Number Publication Date
ES2090790T3 true ES2090790T3 (es) 1996-10-16

Family

ID=16215909

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93111255T Expired - Lifetime ES2090790T3 (es) 1992-07-15 1993-07-15 Derivados de glicolipidos.

Country Status (8)

Country Link
US (1) US5369096A (es)
EP (1) EP0579196B1 (es)
JP (1) JPH0680687A (es)
AT (1) ATE138383T1 (es)
CA (1) CA2100412A1 (es)
DE (1) DE69302767T2 (es)
DK (1) DK0579196T3 (es)
ES (1) ES2090790T3 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
EP0648223A4 (en) * 1992-06-29 1996-07-31 Glycomed Inc SUBSTITUTED LACTOSE DERIVATIVES FOR USE AS CELL ADHESION INHIBITORS.
US5591835A (en) * 1992-06-29 1997-01-07 Glycomed Incorporated Substituted lactose derivatives
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
JPH0899989A (ja) * 1994-09-30 1996-04-16 Akira Hasegawa 新規糖脂質誘導体およびその製造用中間体
AU5911196A (en) * 1995-06-13 1997-01-09 Nisshin Oil Mills, Ltd., The Antiasthmatic agent
BR9609285A (pt) * 1995-06-29 1999-05-11 Novartis Ag Dióis-1,2 diglicosilados como miméticos do sialil-lewis x e do sialil-lewis a
US6008203A (en) * 1995-07-14 1999-12-28 Glycotech Corp. Methods for treatment of EGF receptor associated cancers
US5876715A (en) * 1995-08-17 1999-03-02 The Biomembrane Institute Antibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereof
US6492337B1 (en) 1997-12-30 2002-12-10 A+ Science Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complication
JP2001352982A (ja) * 2000-06-12 2001-12-25 Shimadzu Corp 核酸合成法
JP5183010B2 (ja) 2002-05-16 2013-04-17 グリコミメティクス， インコーポレイテッド セレクチンによって媒介される機能を阻害するための化合物および方法
AU2003245595A1 (en) * 2002-07-03 2004-01-23 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
ATE383367T1 (de) * 2003-11-19 2008-01-15 Glycomimetics Inc Spezifischer antagonist sowohl für e- als auch p- selektine
US20050187171A1 (en) * 2003-11-19 2005-08-25 Glycomimetics, Inc. Glycomimetic antagonists for both E-and P-selectins
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
CA2618638C (en) * 2005-08-09 2014-03-11 Glycomimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
SI2264043T1 (en) * 2005-09-02 2018-01-31 Glycomimetics, Inc. HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
WO2008060378A2 (en) 2006-10-12 2008-05-22 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
EP2457573A1 (en) * 2007-02-09 2012-05-30 GlycoMimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
US8039442B2 (en) * 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2009152245A1 (en) 2008-06-13 2009-12-17 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
JP5726171B2 (ja) * 2009-05-01 2015-05-27 グリコミメティックス インコーポレイテッド Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
CA2858099C (en) 2011-12-22 2020-12-15 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
WO2014089269A1 (en) 2012-12-07 2014-06-12 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
WO2016089872A1 (en) 2014-12-03 2016-06-09 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
US11072625B2 (en) 2016-10-07 2021-07-27 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
CN111867601A (zh) 2018-03-05 2020-10-30 糖模拟物有限公司 用于治疗急性髓系白血病及相关病症的方法
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509313A1 (fr) * 1981-07-08 1983-01-14 Choay Sa Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
US4762800A (en) * 1984-04-26 1988-08-09 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human teratocarcinomas
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
WO1991019501A1 (en) * 1990-06-15 1991-12-26 Cytel Corporation Intercellular adhesion mediators
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5143712A (en) * 1990-07-30 1992-09-01 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
NZ240316A (en) * 1990-10-25 1996-12-20 Univ Michigan Compound for treating disease mediated by the elaboration of elam-1 on endothelial cells

Also Published As

Publication number Publication date
JPH0680687A (ja) 1994-03-22
EP0579196A1 (en) 1994-01-19
EP0579196B1 (en) 1996-05-22
DE69302767D1 (de) 1996-06-27
ATE138383T1 (de) 1996-06-15
DK0579196T3 (da) 1996-07-01
US5369096A (en) 1994-11-29
CA2100412A1 (en) 1994-01-16
DE69302767T2 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
ES2090790T3 (es) Derivados de glicolipidos.
ES2097653T3 (es) Nuevos derivados de desoxigalactonojirimicina.
FR2533210B1 (es)
NO940550L (es)
HUT49860A (en) Process for producing benzamide-type protease inhibitors
ATE61374T1 (de) Diaminoandrostanderivate.
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
DE69132651T2 (de) Schwefel enthaltende heterocyclische Verbindungen
AU2321688A (en) Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
HU9400491D0 (en) Acyl-coenzyme-a=cholesterol acyl-transferase (acat) inhibitor tetrazole-carboxamide derivatives
FI913067A (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
MX170732B (es) Composicion de derivados de succinimida y su uso
SI0668279T1 (en) 6-Azaindole thromboxane synthase inhibitors
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DE69106386D1 (en) Oxysulfonylcarbamate.
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
DE69103985T2 (de) N-Alkylthiazolidinderivate.
FR2541267B1 (es)
DE69333903D1 (de) Optisch aktive 1-Phenylpyrrolidonderivate
TH2690EX (th) อนุพันธ์ต่างๆ ของไนโตรเมทธิลีนสารต่างๆ ที่ใช้ในการสังเคราะห์สารดังกล่าวเหล่านี้กรรมวิธีต่างๆในการผลิตสารเหล่านี้และยาฆ่าแมลงต่างๆ

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579196

Country of ref document: ES

FG2A Definitive protection

Ref document number: 579196

Country of ref document: ES